State of New Jersey Common Pension Fund D’s Ultragenyx Pharmaceutical RARE Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$902K	Sell	27,022 -2,653	-9%	-$65.9K	﹤0.01%	1563
2026 Q1	$622K	Buy	29,675 +71	+0.2%	+$1.6K	﹤0.01%	1437
2025 Q4	$681K	Sell	29,604 -42,451	-59%	-$1.4M	﹤0.01%	1421
2025 Q3	$2.17M	Buy	72,055 +19,015	+36%	+$570K	0.01%	1125
2025 Q2	$1.93M	Buy	53,040 +6,804	+15%	+$245K	0.01%	1222
2025 Q1	$1.67M	Sell	46,236 -278	-0.6%	-$11.6K	0.01%	1352
2024 Q4	$1.96M	Buy	46,514 +11,745	+34%	+$583K	0.01%	1308
2024 Q3	$1.93M	Sell	34,769 -13,995	-29%	-$713K	0.01%	1362
2024 Q2	$2M	Sell	48,764 -6,721	-12%	-$287K	0.01%	1003
2024 Q1	$2.59M	Sell	55,485 -9,583	-15%	-$452K	0.01%	1452
2023 Q4	$3.11M	Sell	65,068 -3,269	-5%	-$127K	0.01%	954
2023 Q3	$2.44M	Buy	68,337 +18,045	+36%	+$715K	0.01%	1101
2023 Q2	$2.32M	Hold	50,292	–	–	0.01%	1494
2023 Q1	$2.02M	Sell	50,292 -17,049	-25%	-$732K	0.01%	1466
2022 Q4	$3.12M	Buy	67,341 +20,052	+42%	+$789K	0.01%	834
2022 Q3	$1.96M	Hold	47,289	–	–	0.01%	1437
2022 Q2	$2.82M	Buy	47,289 +2,951	+7%	+$182K	0.01%	893
2022 Q1	$3.22M	Buy	44,338 +2,054	+5%	+$143K	0.01%	952
2021 Q4	$3.56M	Buy	42,284 +152	+0.4%	+$12.4K	0.01%	920
2021 Q3	$3.8M	Buy	42,132 +2,562	+6%	+$232K	0.01%	869
2021 Q2	$3.77M	Buy	39,570 +1,210	+3%	+$126K	0.01%	890
2021 Q1	$4.37M	Buy	38,360 +305	+0.8%	+$41.5K	0.02%	808
2020 Q4	$5.27M	Sell	38,055 -2,549	-6%	-$302K	0.02%	684
2020 Q3	$3.34M	Sell	40,604 -492	-1%	-$40.8K	0.01%	833
2020 Q2	$3.21M	Sell	41,096 -17,848	-30%	-$1.18M	0.01%	848
2020 Q1	$2.62M	Hold	58,944	–	–	0.01%	860
2019 Q4	$2.52M	Buy	58,944 +13,144	+29%	+$542K	0.01%	1181
2019 Q3	$1.96M	Buy	45,800 +36,400	+387%	+$1.98M	0.01%	1411
2019 Q2	$597K	Hold	9,400	–	–	﹤0.01%	868
2019 Q1	$652K	Hold	9,400	–	–	﹤0.01%	856
2018 Q4	$409K	Hold	9,400	–	–	﹤0.01%	878
2018 Q3	$718K	Hold	9,400	–	–	﹤0.01%	869
2018 Q2	$723K	Hold	9,400	–	–	﹤0.01%	896
2018 Q1	$479K	Hold	9,400	–	–	﹤0.01%	906
2017 Q4	$436K	Hold	9,400	–	–	﹤0.01%	894
2017 Q3	$501K	Hold	9,400	–	–	﹤0.01%	899
2017 Q2	$584K	Hold	9,400	–	–	﹤0.01%	874
2017 Q1	$637K	Hold	9,400	–	–	﹤0.01%	867
2016 Q4	$661K	Hold	9,400	–	–	﹤0.01%	856
2016 Q3	$667K	Hold	9,400	–	–	﹤0.01%	852
2016 Q2	$460K	Hold	9,400	–	–	﹤0.01%	878
2016 Q1	$595K	Hold	9,400	–	–	﹤0.01%	870
2015 Q4	$1.05M	Hold	9,400	–	–	﹤0.01%	838
2015 Q3	$905K	Hold	9,400	–	–	﹤0.01%	852
2015 Q2	$962K	Hold	9,400	–	–	﹤0.01%	842
2015 Q1	$584K	Hold	9,400	–	–	﹤0.01%	891
2014 Q4	$412K	Hold	9,400	–	–	﹤0.01%	926
2014 Q3	$532K	Hold	9,400	–	–	﹤0.01%	888
2014 Q2	$422K	Buy	+9,400	New	+$387K	﹤0.01%	889

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

State of New Jersey Common Pension Fund D's RARE Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Ultragenyx Pharmaceutical (RARE) stake by 8.9% in Q2 2026, selling an estimated $65.9K and leaving 27,022 shares worth $902K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

State of New Jersey Common Pension Fund D first reported a position in RARE in Q2 2014 and has held it in 49 quarters since. The position peaked at $5.27M in Q4 2020. 132 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

State of New Jersey Common Pension Fund D held 27,022 shares of Ultragenyx Pharmaceutical worth $902K as of Q2 2026.
State of New Jersey Common Pension Fund D sold 2,653 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $65.9K.
Ultragenyx Pharmaceutical made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1563 holding.
State of New Jersey Common Pension Fund D first reported a position in Ultragenyx Pharmaceutical in Q2 2014 and has held it in 49 quarters since.
State of New Jersey Common Pension Fund D's Ultragenyx Pharmaceutical position peaked at $5.27M in Q4 2020.
132 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.